Table 3.
Univariate analysis of the demographic and clinical characteristics of patients with or without concomitant SARS-CoV-2 (COVID-19) that were included in a retrospective case–control study that aimed to identify the strains of carbapenem-resistant Enterobacteriaceae and the risk factors associated with acquiring these infections.
| Characteristic | Patients with COVID-19n = 38 | Patients without COVID-19n = 26 | Statistical analysisa |
|---|---|---|---|
| Sex, male | 30 (78.95) | 15 (57.69) | NS |
| Mean age, years | 64.86 | 64.15 | NS |
| Median Charlson Comorbidity Index score | 3.23 | 3.77 | – |
| Charlson Comorbidity Index score 1–4 | 35 (92.11) | 22 (84.62) | NS |
| Charlson Comorbidity Index score >4 | 18 (47.37) | 16 (61.54) | NS |
| Previous hospitalization | 6 (15.79) | 14 (53.85) | P < 0.001 |
| Previous antibiotic therapy | 24 (63.16) | 12 (46.15) | NS |
| Leukopenia at admission | 32 (84.21) | 14 (53.85) | P = 0.008 |
| C-reactive protein >5 mg/l at admission | 35 (92.11) | 24 (92.31) | NS |
| Invasive mechanical ventilation | 12 (31.58) | 2 (7.69) | P = 0.023 |
| Median length of stay in ICU, days | 10.40 | 9.46 | – |
| Length of stay in ICU > 3 days | 34 (89.47) | 19 (73.08) | NS |
Data presented as n of patients (%), mean or median.
aχ2-test; NS, no significant between-group difference (P > 0.05).
ICU, intensive care unit.